D. De Bernardini

CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine

M. Simmaco, P. Martelletti, L. Lionetto, 2021, Journal of clinical medicine.

Polyamines serum levels in episodic and chronic migraine

F. Nicoletti, M. Simmaco, R. Manetti, 2020, Expert review of neurotherapeutics.

Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays

M. Simmaco, M. Borro, G. Gentile, 2022, International journal of molecular sciences.

Psychotropic Drugs Levels in Seminal Fluid: A New Therapeutic Drug Monitoring Analysis?

M. Simmaco, D. Santi, M. Curto, 2021, Frontiers in Endocrinology.

Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study.

F. Nicoletti, P. Marchetti, A. Aceti, 2020, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

Zavegepant. Calcitonin gene-related peptide (CGRP) receptor antagonist, Treatment of migraine

P. Martelletti, L. Lionetto, M. Capi, 2021, Drugs of the Future.